Archive for September, 2005
Merck hid data on deaths from Vioxx
You would expect that a drug company existed not just for shareholders and the FDA but also for patients. Well, apparently Merck exists only for its stockholders and the FDA. When patients during a trial on Alzheimer’s patients started to die, Merck told the FDA so that it would complete its legal obligation but did [...]
Merck was aware of deaths but continued to sell Vioxx
In the ongoing Humeston versus Merck trial in Atlantic City, New Jersey, a few remarkable revelations have come out in the cross examination of David Anstice, a senior level Merck executive, who also played an instrumental role in how Vioxx was marketed. Below are some key points that Mr. Anstice made under cross examination: Merck [...]
Richard Kronmal suggests Merck let patients die
The trial in Atlantic City, New Jersey, in the case against Merck brought by Frederick “Mike” Humeston, a clear storyline is emerging that Merck scientists and other business executives knew that Vioxx had serious safety issues but were under too much pressure from Wall Street and Pfizer to still go ahead and sell the drug. [...]